We’ve released new findings from our open-label extension studies at #ENDO2025. Read more in our latest press release: bit.ly/40jlwVA

It’s Day 3 at #ENDO2025, and science keeps coming. Join us for today’s presentations on pituitary and thyroid research, plus two expert-led product theaters. Here’s where to find us today: • 9:30–10:30 AM – Science and Innovation Theater: Long-term control in acromegaly (Theater

#ENDO2025: Join us at 9:30am for a Crinetics Science and Innovation Theater focused on optimizing long-term control in acromegaly. We'll explore why consistency in treatment matters and how it may reshape patient outcomes. 📍 Theater 1 | ⏰ 9:30–10:30 AM

Happening at 12:30pm today: Crinetics returns to the stage at #ENDO2025 with a deep dive into the challenges of acromegaly care — and how clinical insights are helping navigate complexity with clarity. 📍 Theater 1 | ⏰ 12:30–1:30 PM

We’re excited to be on the ground at #ENDO2025! Stop by Booth 509 to see how Crinetics is driving the future of endocrinology. 📍 Booth 509 | 📸 Let’s talk science.

Live from #ENDO2025: Cushing’s is complex — Dr. Antonio Ribeiro-Oliveira, Jr. explains why. Hear his candid look at a complex condition.

Live from #ENDO2025: What’s changing in endocrinology — and why now? Dr. Bob Cuddihy shares his take on where endocrinology is headed, and how patient voices are shaping clinical development in new ways.

Live from #ENDO2025: Dr. Raffaella Colzani shares how receptor biology is opening new doors.

Thank you to everyone who joined us at #ENDO2025. We were proud to present new data supporting our mission to advance care in endocrinology. See highlights from the event!

A new 4-paper series authored by Crinetics researchers is now publishing in the Journal of Comparative Effectiveness Research. The series has been selected for the journal’s “Real-World Evidence in the Spotlight” webinar on July 31. Register for the webinar here:

Join us tomorrow with Dr. Shlomo Melmed of Cedars-Sinai for a virtual discussion exploring the progressive nature of acromegaly and its daily impact on patients. The session will address challenges in diagnosis, symptom burden and the complexities of long-term management.

Meet the true leader behind our people operations – Coco, the faithful companion to our Chief Human Resources Officer, Adriana Cabré. Together, they foster our unique company culture and ensure that we attract the very best two-legged AND four-legged talent! Want to learn more

#CRNX announces second quarter financial results and provides a business update for 2025. Learn more: bit.ly/4llrqNj

We’re pleased to welcome Dr. Divya Yogi-Morren of Cleveland Clinic tomorrow, August 13 for an insightful virtual presentation on acromegaly, highlighting the importance of achieving biochemical control and reducing symptom burden. Register here to learn more:

Introducing the Patient IGF-1 Calculator, a new resource designed to help understand IGF-1 levels and support conversations between patients and healthcare providers: bit.ly/45SoC4X

The U.S. FDA has granted Orphan Drug Designation to our novel, once-daily, oral ACTH receptor antagonist candidate for the proposed treatment of classic congenital adrenal hyperplasia (CAH). Read more: bit.ly/45E4hQt

Join us tomorrow with Dr. Nidhi Agrawal of NYU Langone Health for a virtual conversation focused on the progressive nature of acromegaly and its impact on daily life. The session will explore clinical challenges, current treatment limitations, and practical case examples to

A new Phase 3 clinical trial in congenital adrenal hyperplasia (CAH) is now underway. To receive more information about the study, register your interest here: bit.ly/464t5l9

At Crinetics, patients guide our science every step of the way, from early discovery to clinical trials and beyond. Their lived experiences shape our understanding of disease, inform our research priorities, and help design more meaningful clinical trials. Learn about our

We’ve given our website a new look and feel to make key information easier than ever to find and explore. Click play to take a short tour.